Publications

Book Chapters

Research Papers

2.      Sharma R, Jain H, Pratibha, Godugu C, Chella N. Formulation and optimization of aceclofenac loaded hyaluronic-oleic acid based micellar gel for the management of osteoarthritis. J Drug Deliv Sci Technol. 2023;84.

3.      Pal LB, Bule P, Khan W, Chella N. An Overview of the Development and Preclinical Evaluation of Antibody–Drug Conjugates for Non-Oncological Applications. Pharmaceutics. 2023 Jun 24;15(7):1807.

4.      Syamprasad NP, Madje N, Bachannagari J, Jannu AK, Jain S, Tene K, et al. Niclosamide nanocrystal for enhanced in-vivo efficacy against gastrointestinal stromal tumor via regulating EGFR/STAT-3/DR-4 axis. J Drug Deliv Sci Technol. 2023;81.

5.      Nayakula M, Jeengar MK, Naidu VGM, Chella N. Enhanced Pharmacokinetics and Anti-inflammatory Activity of Curcumin Using Dry Emulsion as Drug Delivery Vehicle. Eur J Drug Metab Pharmacokinet. 2023;48(2):189–99.

6.      Padakanti AP, Pawar SD, Kumar P, Chella N. Development and validation of HPLC method for simultaneous estimation of erlotinib and niclosamide from liposomes optimized by screening design. J Liposome Res. 2023;

7.      Ghosh A, Ghosh B, Parihar N, Ilaweibaphyrnai M, Panda SR, Alexander A, et al. Nutraceutical prospects of Houttuynia cordata against the infectious viruses. Food Biosci. 2022;50.

8.      Ganthala PD, Alavala S, Chella N, Andugulapati SB, Bathini NB, Sistla R. Co-encapsulated nanoparticles of Erlotinib and Quercetin for targeting lung cancer through nuclear EGFR and PI3K/AKT inhibition. Colloids Surf B Biointerfaces [Internet]. 2022 Mar;211:112305. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0927776521007517

9.      Jannu AK, Puppala ER, Gawali B, Syamprasad NP, Alexander A, Marepally S, et al. Lithocholic acid-tryptophan conjugate (UniPR126) based mixed micelle as a nano carrier for specific delivery of niclosamide to prostate cancer via EphA2 receptor. Int J Pharm. 2021;605.

10.    Saka R, Chella N, Khan W. Development of Imatinib Mesylate-Loaded Liposomes for Nose to Brain Delivery: In Vitro and In Vivo Evaluation. AAPS PharmSciTech. 2021;22(5).

11.    Rampaka R, Ommi K, Chella N. Role of solid lipid nanoparticles as drug delivery vehicles on the pharmacokinetic variability of Erlotinib HCl. J Drug Deliv Sci Technol. 2021 Dec;66:102886. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1773224721005669

12.    Jain H, Chella N. Methods to improve the solubility of therapeutical natural products: a review. Environ Chem Lett. 2021;19(1):111–21.

13.    Saka R, Chella N. Nanotechnology for delivery of natural therapeutic substances: a review. Environ Chem Lett. 2021;19(2):1097–106.

14.    Saka R, Jain H, Kommineni N, Chella N, Khan W. Enhanced penetration and improved therapeutic efficacy of bexarotene via topical liposomal gel in imiquimod induced psoriatic plaque model in BALB/c mice. J Drug Deliv Sci Technol. 2020;58.

15.    Kommineni N, Pandi P, Chella N, Domb AJ, Khan W. Antibody drug conjugates: Development, characterization, and regulatory considerations. Polym Adv Technol. 2020;31(6):1177–93.

16.    Lodagekar A, Chavan RB, Mannava MKC, Yadav B, Chella N, Nangia AK, et al. Co amorphous valsartan nifedipine system: Preparation, characterization, in vitro and in vivo evaluation. European Journal of Pharmaceutical Sciences. 2019;139.

17.    Lodagekar A, Borkar RM, Thatikonda S, Chavan RB, Naidu VGM, Shastri NR, et al. Formulation and evaluation of cyclodextrin complexes for improved anticancer activity of repurposed drug: Niclosamide. Carbohydr Polym [Internet]. 2019 May;212:252–9. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0144861719301833

18.    Lodagekar A, Chavan RB, Chella N, Shastri NR. Role of Valsartan as an Antiplasticizer in Development of Therapeutically Viable Drug-Drug Coamorphous System. Cryst Growth Des. 2018;18(4):1944–50.

19.    Daravath B, Naveen C, Vemula SK, Tadikonda RR. Solubility and dissolution enhancement of flurbiprofen by solid dispersion using hydrophilic carriers. Brazilian Journal of Pharmaceutical Sciences. 2018 May 7;53(4).

20.    Nooli M, Chella N, Kulhari H, Shastri NR, Sistla R. Solid lipid nanoparticles as vesicles for oral delivery of olmesartan medoxomil: formulation, optimization and in vivo evaluation. Drug Dev Ind Pharm. 2017;43(4):611–7.

21.    Johnsirani P, Ch. V, Lingesh A, Naidu VGM, Ch. N, Satheeshkumar N. Isolation, characterization using LC-ESI-QTOF, NMR and in vitro cytotoxicity assay of niclosamide forced degradation products. J Pharm Biomed Anal. 2017;136.

22.    Jeengar MK, Rompicharla SVK, Shrivastava S, Chella N, Shastri NR, Naidu VGM, et al. Emu oil based nano-emulgel for topical delivery of curcumin. Int J Pharm. 2016;506(1–2):222–36.

23.    Chella N, Daravath B, Kumar D, Tadikonda RR. Formulation and Pharmacokinetic Evaluation of Polymeric Dispersions Containing Valsartan. Eur J Drug Metab Pharmacokinet. 2016;41(5):517–26.

24.    Bari A, Chella N, Sanka K, Shastri NR, Diwan PV. Improved anti-diabetic activity of glibenclamide using oral self nano emulsifying powder. J Microencapsul. 2015;32(1):54–60.

25.    Narayana L, Chella N, Kumar D, Shastri NR. Design of a novel type IV lipid-based delivery system for improved delivery of drugs with low partition coefficient. J Liposome Res. 2015;25(4):325–33.

26.    Chella N, Tadikonda R. Melt dispersion granules: Formulation and evaluation to improve oral delivery of poorly soluble drugs-a case study with valsartan. Drug Dev Ind Pharm. 2015;41(6):888–97.

27.    Chella N, Narra N, Rama Rao T. Preparation and Characterization of Liquisolid Compacts for Improved Dissolution of Telmisartan. J Drug Deliv. 2014 Oct 12;2014:1–10.

28.    VGM Naidu WKCNYVG. Nano Boom: Opportunities in India. Nano Digest. 2013;4(7):28–31.

29.    Chella N, Shastri N, Tadikonda RR. Use of the liquisolid compact technique for improvement of the dissolution rate of valsartan. Acta Pharm Sin B. 2012;2(5):502–8.

30.    Naveen Chella KKYRV. Preparation and evaluation of ethyl cellulose microspheres containing diclofenac sodium by novel w/o/o emulsion method. Journal of Pharmaceutical Sciences and Research. 2010;2(12):884–8.